Prosecution Insights
Last updated: May 29, 2026

BIOGAIA AB

5 pending office actions • 4 art units • 4 examiners • 0 of 5 (0%) have an AI response strategy ready

Portfolio Summary

5
Total Pending OAs
2
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
2
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (2)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
5
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only5 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MOAZZAMI, NAGHMEH NINA 2 71.7% +42.8%
DUBOIS, PHILIP A 1 25.0% +25.4%
CURRENS, GRANT CARSON 1 53.1% +64.1%
VAN BUREN, LAUREN K 1 38.9% +57.3%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18450498 Product for the Storage of Freeze-Dried Lactic Acid Bacteria Mixed with Oral Rehydration Solution DUBOIS, PHILIP A 43d overdue

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18060626 HISTAMINE-PRODUCING BACTERIAL STRAINS AND THEIR USE IN CANCER VAN BUREN, LAUREN K 51d overdue
18450498 Product for the Storage of Freeze-Dried Lactic Acid Bacteria Mixed with Oral Rehydration Solution DUBOIS, PHILIP A 43d overdue
18002184 GOS PRE-CONDITIONING L. REUTERI AND GOS IN FINAL FORMULATION MOAZZAMI, NAGHMEH NINA 14d
18002163 PRE-CONDITIONING OF L.REUTERI MOAZZAMI, NAGHMEH NINA 15d
18002670 PROBIOTIC COMPOSITION FOR TOPICAL USE CURRENS, GRANT CARSON 33d

Top Art Units

Art UnitApps
1652 2
1791 1
1651 1
1638 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18450498 Product for the Storage of Freeze-Dried Lactic Acid Bacteria Mixed with Oral Rehydration Solution DUBOIS, PHILIP A 1791 §103 Non-Final OA 43d overdue Pending Aug 16, 2023
18002670 PROBIOTIC COMPOSITION FOR TOPICAL USE CURRENS, GRANT CARSON 1651 §103 Final Rejection 33d Pending Dec 21, 2022
18002184 GOS PRE-CONDITIONING L. REUTERI AND GOS IN FINAL FORMULATION MOAZZAMI, NAGHMEH NINA 1652 §103 Final Rejection 14d Pending Dec 16, 2022
18002163 PRE-CONDITIONING OF L.REUTERI MOAZZAMI, NAGHMEH NINA 1652 §103 Final Rejection 15d Pending Dec 16, 2022
18060626 HISTAMINE-PRODUCING BACTERIAL STRAINS AND THEIR USE IN CANCER VAN BUREN, LAUREN K 1638 §103 Non-Final OA 51d overdue Pending Dec 01, 2022

Managing BIOGAIA AB's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month